|
UPF2 expression based on
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.149400E-01 |
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 4 samples. One sample from American Indian patient is not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.117200E-01 |
| Normal-vs-AfricanAmerican |
4.479800E-01 |
| Normal-vs-Asian |
6.824400E-01 |
| Caucasian-vs-AfricanAmerican |
6.709600E-01 |
| Caucasian-vs-Asian |
8.117400E-01 |
| AfricanAmerican-vs-Asian |
7.351200E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.684000E-01 |
| Normal-vs-Female |
4.512800E-01 |
| Male-vs-Female |
9.387200E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Four samples from patients aged below 21 are not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.916000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.512400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.896600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.738500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.150300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.714200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.691400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.857400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.523600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.319200E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Paraganglioma |
3.273000E-01 |
| Normal-vs-Pheochromocytoma |
4.097200E-01 |
| Normal-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
7.587600E-01 |
| Paraganglioma-vs-Pheochromocytoma |
4.746200E-01 |
| Paraganglioma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
8.275600E-02 |
| Pheochromocytoma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
1.370590E-01 |
|
|
